United Therapeutics (UTHR) Times Interest Earned (2009 - 2026)

United Therapeutics has disclosed Times Interest Earned across 18 years of filings, most recently posting $108.6 for Q1 2026.

• Times Interest Earned for Q1 2026 came in at $108.6, up 73.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $87.53 (up 122.65% YoY), and the FY2025 annual result was $76.54, up 138.45% from the prior year.
• Times Interest Earned came in at $108.6 for Q1 2026 at United Therapeutics, down from $115.06 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $129.5 in Q3 2025 to a low of $14.28 in Q4 2022.
• The 5-year median for Times Interest Earned is $33.97 (2024), against an average of $48.34.
• Across the five-year window, Times Interest Earned soared 534.99% in 2022 and sank 66.37% in 2023, its largest moves.
• United Therapeutics' Times Interest Earned stood at $14.28 in 2022, then grew by 20.65% to $17.23 in 2023, then soared by 162.86% to $45.28 in 2024, then surged by 154.13% to $115.06 in 2025, then decreased by 5.62% to $108.6 in 2026.
• The last three Times Interest Earned figures came in at $108.6 (Q1 2026), $115.06 (Q4 2025), and $129.5 (Q3 2025), per Business Quant data.